Mast cell activation by glia maturation factor, 1-methyl-4-phenylpyridinium and α-synuclein: implications for Parkinson's disease

被引：0
|
作者：
Zaheer, Asgar [1 ,2 ]
Kempuraj, Duraisamy [1 ]
Khan, Mohammad [1 ]
Javed, Hayate [1 ]
Zaheer, Smita [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Neurol VAHCS, Iowa City, IA USA
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
596.5
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Mitochondrial Fragmentation Mediates 1-methyl-4-phenylpyridinium Toxicity in Neurons: Implication for Parkinson Disease (PD)
    Zhu, Xiongwei
    Su, Bo
    Gao, Yuan
    Castellani, Rudy
    Perry, George
    Smith, Mark
    Wang, Xinglong
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2011, 70 (06): : 504 - 505
  • [12] Myeloid cell leukemia 1 (Mcl−1) protects against 1-methyl-4-phenylpyridinium ion (MPP+) induced apoptosis in Parkinson’s disease
    Lijing Fan
    Li Jiang
    Zhongde Du
    Metabolic Brain Disease, 2015, 30 : 1269 - 1274
  • [13] Glia Maturation Factor Deficiency Suppresses 1-Methyl-4-Phenylpyridinium-Induced Oxidative Stress in Astrocytes
    Khan, Mohammad Moshahid
    Kempuraj, Duraisamy
    Zaheer, Smita
    Zaheer, Asgar
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2014, 53 (04) : 590 - 599
  • [14] Glia Maturation Factor Deficiency Suppresses 1-Methyl-4-Phenylpyridinium-Induced Oxidative Stress in Astrocytes
    Mohammad Moshahid Khan
    Duraisamy Kempuraj
    Smita Zaheer
    Asgar Zaheer
    Journal of Molecular Neuroscience, 2014, 53 : 590 - 599
  • [15] Glia Maturation Factor Dependent Mast Cell Activation and Calpain 1 Synergize Dopaminergic Neuronal Loss and Behavioral Deficits in an MPTP Mouse Model of Parkinson's Disease
    Pushpavathi, Selvakumar Govindhasamy
    Duraisamy, Kempuraj
    Ahmed, Mohammad Ejaz
    Thangavel, Ramasamy
    Dubova, Iuliia
    Mentor, Shireen
    Saeed, Daniyal
    Zaheer, Smita
    Raikwar, Sudhanshu P.
    Iyer, Shankar S.
    Zaheer, Asgar
    FASEB JOURNAL, 2019, 33
  • [16] α-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity
    Jensen, PJ
    Alter, BJ
    O'Malley, KL
    JOURNAL OF NEUROCHEMISTRY, 2003, 86 (01) : 196 - 209
  • [17] Myeloid cell leukemia 1 (Mcl-1) protects against 1-methyl-4-phenylpyridinium ion (MPP plus ) induced apoptosis in Parkinson's disease
    Fan, Lijing
    Jiang, Li
    Du, Zhongde
    METABOLIC BRAIN DISEASE, 2015, 30 (05) : 1269 - 1274
  • [18] 1-methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis
    Leist, M
    Volbracht, C
    Fava, E
    Nicotera, P
    MOLECULAR PHARMACOLOGY, 1998, 54 (05) : 789 - 801
  • [19] Regulatory Role and Molecular Mechanism of Mammalian Sterile 20-Like Kinase 1 in 1-Methyl-4-Phenylpyridinium Ion-Induced Parkinson's Disease Cell Model
    Zhang, Jun
    Liu, Jie
    Li, Yongle
    Zhang, Xuexian
    Yang, Chunxiang
    REJUVENATION RESEARCH, 2024, 27 (05) : 154 - 162
  • [20] UPTAKE OF 1-METHYL-4-PHENYLPYRIDINIUM AND DOPAMINE IN THE MOUSE-BRAIN CELL-NUCLEI
    BUU, NT
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 (04) : 1557 - 1560
12345